Andreas Halvorsen's position in BridgeBio Pharma is currently worth $1.24B. That's 3.04% of their equity portfolio (9th largest holding). The investor owns 7.35% of the outstanding BridgeBio Pharma stock. Andreas Halvorsen started to build up the position in BridgeBio Pharma in Q2 2019. Since then they sold 12.2M shares. The stake costed the investor $397M, netting the investor a gain of 212% so far.